![Richard Rudick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Rudick
Directeur/Membre du Conseil chez
IMMUNIC, INC.
Fortune : 364 000 $ au 31/08/2026
Profil
Dr. Richard A. Rudick, MD, is an Independent Director at Immunic, Inc. He is on the Board of Directors at Immunic, Inc. Dr. Rudick was previously employed as a Vice President-Development Sciences by Biogen, Inc. He received his doctorate degree from Case Western Reserve University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNIC, INC. 0,17 % | 05/07/2026 | 23 038 ( 0,17 % ) | 364 000 $ | 31/08/2026 |
Postes actifs de Richard Rudick
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | Directeur/Membre du Conseil | 26/04/2023 |
Anciens postes connus de Richard Rudick
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/08/2020 |
Formation de Richard Rudick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Case Western Reserve University School of Medicine
 Case Western Reserve University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
